These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6141519)
21. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094 [TBL] [Abstract][Full Text] [Related]
22. Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics. Cobelli C; Pacini G Diabetes; 1988 Feb; 37(2):223-31. PubMed ID: 3292317 [TBL] [Abstract][Full Text] [Related]
23. Selective suppression of hepatic glucose output by human proinsulin in the dog. Lavelle-Jones M; Scott MH; Kolterman O; Rubenstein AH; Olefsky JM; Moossa AR Am J Physiol; 1987 Feb; 252(2 Pt 1):E230-6. PubMed ID: 2881485 [TBL] [Abstract][Full Text] [Related]
24. Somatostatin does not alter insulin-mediated glucose disposal. Meneilly GS; Elahi D; Minaker KL; Rowe JW J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337 [TBL] [Abstract][Full Text] [Related]
25. The effect of growth hormone on splanchnic glucose and substrate metabolism following oral glucose loading in healthy man. Bratusch-Marrain PR; Gasić S; Waldhäusl WK; Nowotny P Diabetes; 1984 Jan; 33(1):19-25. PubMed ID: 6360765 [TBL] [Abstract][Full Text] [Related]
26. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Sindelar DK; Chu CA; Venson P; Donahue EP; Neal DW; Cherrington AD Diabetes; 1998 Apr; 47(4):523-9. PubMed ID: 9568682 [TBL] [Abstract][Full Text] [Related]
27. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Lewis GF; Carpentier A; Vranic M; Giacca A Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558 [TBL] [Abstract][Full Text] [Related]
29. Quantitative study of insulin secretion and clearance in normal and obese subjects. Polonsky KS; Given BD; Hirsch L; Shapiro ET; Tillil H; Beebe C; Galloway JA; Frank BH; Karrison T; Van Cauter E J Clin Invest; 1988 Feb; 81(2):435-41. PubMed ID: 3276729 [TBL] [Abstract][Full Text] [Related]
30. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk FW; Holst JJ; Rizza RA Diabetes; 2001 Mar; 50(3):565-72. PubMed ID: 11246876 [TBL] [Abstract][Full Text] [Related]
31. Measuring pre-hepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule. Hovorka R; Koukkou E; Southerden D; Powrie JK; Young MA Diabetologia; 1998 May; 41(5):548-54. PubMed ID: 9628272 [TBL] [Abstract][Full Text] [Related]
32. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Lewis GF; Zinman B; Groenewoud Y; Vranic M; Giacca A Diabetes; 1996 Apr; 45(4):454-62. PubMed ID: 8603767 [TBL] [Abstract][Full Text] [Related]
33. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients. Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980 [TBL] [Abstract][Full Text] [Related]
34. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans. Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277 [TBL] [Abstract][Full Text] [Related]
35. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Sindelar DK; Balcom JH; Chu CA; Neal DW; Cherrington AD Diabetes; 1996 Nov; 45(11):1594-604. PubMed ID: 8866566 [TBL] [Abstract][Full Text] [Related]
36. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels. Schmitz O Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853 [TBL] [Abstract][Full Text] [Related]
37. The half-life of endogenous insulin and C-peptide in man assessed by somatostatin suppression. Matthews DR; Rudenski AS; Burnett MA; Darling P; Turner RC Clin Endocrinol (Oxf); 1985 Jul; 23(1):71-9. PubMed ID: 2863015 [TBL] [Abstract][Full Text] [Related]
38. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. Polonsky KS; Pugh W; Jaspan JB; Cohen DM; Karrison T; Tager HS; Rubenstein AH J Clin Invest; 1984 Nov; 74(5):1821-9. PubMed ID: 6389599 [TBL] [Abstract][Full Text] [Related]
39. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs. Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094 [TBL] [Abstract][Full Text] [Related]
40. Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia. Ryan AS; Egan JM; Habener JF; Elahi D J Clin Endocrinol Metab; 1998 Jul; 83(7):2399-404. PubMed ID: 9661618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]